Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company's technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas. Show more
Location: 21 Waterway Avenue, The Woodlands, TX, 77380, United States | Website: https://autonomix.com | Industry: Medical Devices | Sector: Healthcare
Market Cap
5.629M
52 Wk Range
$0.89 - $15.00
Previous Close
$0.91
Open
$0.88
Volume
400,901
Day Range
$0.83 - $0.92
Enterprise Value
-3.444M
Cash
8.589M
Avg Qtr Burn
-2.253M
Insider Ownership
7.73%
Institutional Own.
4.76%
Qtr Updated
06/30/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
